Prof. Dr. Michael Sticherling

Medizinische Fakultät Professur für Entzündungsdermatologie Department of Dermatology

Vision transformer-based diagnosis of psoriasis and eczema in whole-slide histology (2026) Rivera Monroy LC, Petzold A, Sari M, Breininger K, Maier A, Vera González J, Erdmann M, et al. Journal article Harnessing Digital Pathology Tools to Distinguish Hand Eczema From Palmar Psoriasis: A Quantitative Approach (2026) Sari M, Schliep S, Petzold A, Kiesewetter F, Erdmann M, Sticherling M, Berking C, et al. Journal article Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany (2025) Heinrich L, Birkner T, Abraham S, Gerdes S, Honstein T, Müller S, Augustin M, et al. Journal article CD163/CD63+ Monocyte-Derived DC Profiled in Tissue by Multi-Antigen Analysis (MAA) Discriminate Chronic Eczema and Psoriasis (2025) Windorfer S, Kirr M, Fröhlich W, Plosnita B, Ostalecki C, Berking C, Sticherling M, Baur A Journal article Disturbed Spatial WNT Activation—A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis (2025) Chenguiti Fakhouri S, Zhu H, Li YN, Ronicke M, Rigau AR, Dees C, Konstantinidis L, et al. Journal article Inflammatory Skin Diseases: The Importance of Immunological Signatures (2025) Garzorz-Stark N, Weidinger S, Sticherling M, Ghoreschi K, Enk A, Eyerich K Journal article, Review article Serum extracellular matrix biomarkers in rheumatoid arthritis, psoriatic arthritis and psoriasis and their association with hand function (2025) Port H, Coppers B, Tragl S, Manger E, Niemiec LM, Bayat S, Simon D, et al. Journal article, Original article Systemtherapien bei Kindern und Jugendlichen in der Dermatologie (2025) Sticherling M, Süßmuth K Journal article Systemtherapie der Neurodermitis und Psoriasis im Kindes- und Jugendalter (2025) Sticherling M Journal article Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial (2025) Tsianakas A, Passeron T, Magnolo N, Blume-Peytavi U, Kelly V, Day I, Serrao R, et al. Journal article